| Primary
Care Evidence Base |
| DARE,
NHS EED, HTA (Programmes & Databases), Cochrane Library |
| Colour
vision screening: a critical appraisal of the literature. New
Zealand Health Technology Assessment Christchurch: New Zealand Health
Technology Assessment, 1998. pp.59 |
| Analysis
of the MTI Photoscreener for the early detection of visual anomalies
in children. Oliva G, Almazan D Barcelona: Catalan Agency for
Health Technology Assessment, 1997. |
| Preschool
vision screening. Snowdon SK, Stewart-Brown SL Health Technology
Assessment, 1997. pp.85 |
| Pre-school
hearing, speech, language and vision screening. NHS Centre
for Reviews and Dissemination York: NHS Centre for Reviews and Dissemination,
1998. pp.12 |
| Preschool
vision screening: results of a systematic review. NHS Centre
for Reviews and Dissemination; Health Services Research Unit, Dept
of Public Health and Primary Care, University of Oxford York: NHS
Centre for Reviews and Dissemination, 1997. pp.114 |
| Impact
of diabetic retinopathy screening on a British district population:
case detection and blindness prevention in an evidence-based model.
Bachmann M O, Nelson S J. Journal of Epidemiology and Community
Health, 1998, 52 |
| Preschool
vision screening: results of a systematic review. Snowdon S K,
Stewart-Brown S L. CRD Report, 1997, 9, pp.1-114 |
| Effectiveness
of screening older people for impaired vision in community setting:
systematic review of evidence from randomised controlled trials.
Smeeth L, Iliffe S BMJ, 1998, 316, pp. 660-663 |
| Pre-school
hearing, speech, language and vision screening. University
of York. NHS Centre for Reviews and Dissemination. Effective Health
Care, 1998, 4(2), pp.1-12 |
| Assessing
the costs and benefits of medical research: the Diabetic Retinopathy
Study Drummond M F, Davies L M, Ferris F L. Social Science
and Medicine, 1992, 34(9), 973-981 |
| Community
screening for visual impairment in the elderly Smeeth L, Iliffe
S. In: The Cochrane Library, 1, 2001. Oxford: Update Software.
Abstract Link |
| Cost
considerations of medical therapy for glaucoma Fiscella R G, Geller
J L, Gryz L L, Wilensky J, Viana M. American Journal of Ophthalmology,
1999, 128(4), 426-433 |
| Last
updated: February 2001 |
|